These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32048170)

  • 21. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris.
    Charakida A; Charakida M; Chu AC
    Br J Dermatol; 2007 Sep; 157(3):569-74. PubMed ID: 17635508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and comparison of the efficacy and safety of cross-linked and non-cross-linked hyaluronic acid in combination with botulinum toxin type A in the treatment of atrophic acne scars: A double-blind randomized clinical trial.
    Behrangi E; Dehghani A; Sheikhzadeh F; Goodarzi A; Roohaninasab M
    Skin Res Technol; 2024 Jan; 30(1):e13541. PubMed ID: 38174839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficiency of benazepril combined with wind dispelling and dampness removing chinese herbs on stage 3 chronic kidney disease with wind-dampness syndrome: a prospective study].
    Fang YQ; Lu Y; Wang YJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Mar; 32(3):311-6. PubMed ID: 22686073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of
    Kim MJ; Kim KP; Choi E; Yim JH; Choi C; Yun HS; Ahn HY; Oh JY; Cho Y
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33921829
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of Facial Acne Vulgaris by Chinese Medicine Combined Western Medicine].
    Chang XA; Dai S; Ye ZZ; Song QH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2017 Feb; 37(2):160-164. PubMed ID: 30650266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of herbal medicine for dysmenorrhea treatment on accompanied acne vulgaris: a study protocol for a randomized controlled trial.
    Kim KI; Nam HJ; Kim M; Lee J; Kim K
    BMC Complement Altern Med; 2017 Jun; 17(1):318. PubMed ID: 28623918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study.
    Bissonnette R; Poulin Y; Drew J; Hofland H; Tan J
    J Am Acad Dermatol; 2017 Jan; 76(1):33-39. PubMed ID: 28029390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Effects of Oral and Topical Simvastatin in the Treatment of Acne Vulgaris: A Double-blind, Randomized, Placebo-controlled Clinical Trial.
    Ahmadvand A; Yazdanfar A; Yasrebifar F; Mohammadi Y; Mahjub R; Mehrpooya M
    Curr Clin Pharmacol; 2018; 13(4):279-283. PubMed ID: 30129417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
    J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesions and facial heat in patients with acne vulgaris: A randomized controlled trial protocol.
    Kim K; Kim KI; Lee J
    BMC Complement Altern Med; 2016 Jan; 16():21. PubMed ID: 26800893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC; Baldwin H; Stein Gold L; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study.
    Rademaker M; Wishart JM; Birchall NM
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):747-54. PubMed ID: 23617693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of Chinese herbal medicine Qirui Weishu capsule in treating chronic non-atrophic gastritis: A multicentre, double-blind, randomized controlled clinical trial.
    Chen HF; Gong Y; Huang Z; Zhao G; Chen ZM; Zen YM; Li HZ; Hu YL
    J Ethnopharmacol; 2022 Aug; 294():115341. PubMed ID: 35551978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
    Santer M; Lawrence M; Renz S; Eminton Z; Stuart B; Sach TH; Pyne S; Ridd MJ; Francis N; Soulsby I; Thomas K; Permyakova N; Little P; Muller I; Nuttall J; Griffiths G; Thomas KS; Layton AM;
    BMJ; 2023 May; 381():e074349. PubMed ID: 37192767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
    Redmond GP; Olson WH; Lippman JS; Kafrissen ME; Jones TM; Jorizzo JL
    Obstet Gynecol; 1997 Apr; 89(4):615-22. PubMed ID: 9083323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.